CDMO Education Centre

close
08 Aug 2024

Advancing Allogeneic CAR T Cell Therapies: Overcoming Challenges in Workflow and Manufacturing

Autologous chimeric antigen receptor (CAR) T cell therapies have shown...

Tell us what you thought about this post.

You may also like: